Quest Diagnostics has launched a new suite of Return to Work services built around large-scale workforce COVID-19 testing. The services are designed to help organizations access and act on COVID-19 laboratory insights in order to foster safer workplace environments for their employees as the nation begins to restart the U.S. economy.
Quest Diagnostics is a leading provider of employee population health and workplace drug testing services, serving thousands of employers across the United States. The company’s services range from lab and biometric screening to behavioral and mental health interventions to telemedicine and flu clinics.
To accommodate expected demand, the company is scaling up its COVID-19 lab operations and expects to have capacity to perform approximately 150,000 molecular diagnostic tests a day by the end of June, compared to approximately 80,000 of these tests a day currently. The company also has capacity to perform approximately 200,000 antibody tests a day.
“Employers of all kinds are trying to put programs in place to help protect their employees and customers as we return to work over the coming months. To be more effective, these programs will need to use high quality laboratory-...